Glucomin 850 mg is a frontline oral hypoglycemic medication manufactured by the Israeli pharmaceutical company Dexcel Pharma, containing Metformin Hydrochloride. Widely recognized as a gold-standard treatment for type 2 diabetes mellitus, Glucomin effectively lowers blood glucose concentrations, enhances peripheral insulin sensitivity, and aids in metabolic weight management.

Indications: Glucomin 850 mg is used for:

• Management of type 2 diabetes mellitus (especially in overweight patients)

• Monotherapy or combination therapy with other oral antidiabetic agents or insulin

• Prevention of type 2 diabetes in individuals with impaired glucose tolerance (prediabetes)

• Management of Polycystic Ovary Syndrome (PCOS) related insulin resistance

• Reducing the risk of cardiovascular complications associated with diabetes

Reasons for Use:

• Elevated fasting and postprandial blood sugar levels

• Insulin resistance and impaired carbohydrate metabolism

• Need for safe, long-term glycemic control without causing hypoglycemia

• Medical recommendation for baseline metabolic stabilization

Key Features:

• Active ingredient — Metformin Hydrochloride 850 mg

• Lowers hepatic glucose production and intestinal glucose absorption

• Does not cause hypoglycemia when used as monotherapy

• Favorably influences lipid profile (reduces total cholesterol and triglycerides)

• Oval-shaped caplet form (30 Caplets) designed for easier swallowing

• Manufactured to high international standards by Dexcel Pharma in Israel

Dosage Form: Glucomin — Caplets, 850 mg (pack of 30 caplets)

Manufacturer: Dexcel Pharma

Active Ingredients:

• Metformin Hydrochloride — 850 mg

#Glucomin #Metformin #DexcelPharma #Type2Diabetes #BloodSugarControl #InsulinResistance #Hypoglycemic #IsraeliMeds #PharmacyIsrael